Literature DB >> 197011

Cellular basis of persistent lymphocytosis in cattle infected with bovine leukemia virus.

S J Kenyon, C E Piper.   

Abstract

Peripheral blood lymphocytes from 14 cattle infected with the bovine leukemia virus (BLV) and 14 BLV-free cattle were examined by the membrane immunofluorescent antibody technique to detect surface immunoglobulin (S-Ig) and by the erythrocyte-antibody-complement (EAC) rosette test for the detection of complement receptors. Direct comparisons of the percentages of S-Ig-bearing cells and EAC rosette-forming cells in both infected and BLV-free animals showed no evidence for the presence of a substantial population bearing one surface marker but not the other. The data showed that cells with surface markers characteristic of B lymphocytes are responsible for most of the increase in peripheral blood lymphocytes which may accompany BLV infection. The release of infectious BLV and the spontaneous uptake of thymidine by short-term cultured peripheral blood lymphocytes from BLV-infected cattle were also studied. The results indicate that both of these activities are function of B lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 197011      PMCID: PMC421046          DOI: 10.1128/iai.16.3.891-897.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  OCCURRENCE OF LYMPHOCYTOSIS IN DAIRY CATTLE HERDS WITH HIGH INCIDENCE OF LYMPHOSARCOMA.

Authors:  R R MARSHAK; W C HARE; D A ABT; J E CROSHAW; J W SWITZER; I IPSEN; R M DUTCHER; J E MARTIN
Journal:  Ann N Y Acad Sci       Date:  1963-11-04       Impact factor: 5.691

2.  [Studies on the number of B and T lymphocytes in the circulating blood of healthy leukosis-suspected and leukosis-affected cattle of the German black and white breed].

Authors:  E Garcia de Lima; E Mitscherlich
Journal:  Zentralbl Veterinarmed B       Date:  1973-11

3.  Characteristics of lymphocyte responses to phytomitogens: comparison of responses of lymphocytes from normal and lymphocytotic cows.

Authors:  C C Muscoplat; I Alhaji; D W Johnson; K A Pomeroy; J M Olson; V L Larson; J B Stevens; D K Sorensen
Journal:  Am J Vet Res       Date:  1974-08       Impact factor: 1.156

4.  Replicating C-type virus in phytohemagglutinin-treated buffy-coat cultures of bovine origin.

Authors:  N D Stock; J F Ferrer
Journal:  J Natl Cancer Inst       Date:  1972-04       Impact factor: 13.506

5.  Virus-like particles in phytohemagglutinin-stimulated lymphocyte cultures with reference to bovine lymphosarcoma.

Authors:  J M Miller; L D Miller; C Olson; K G Gillette
Journal:  J Natl Cancer Inst       Date:  1969-12       Impact factor: 13.506

6.  Frequency of surface immunoglobulin bearing blood lymphocytes in cattle affected with bovine leukosis.

Authors:  F Weiland; O C Straub
Journal:  Res Vet Sci       Date:  1975-07       Impact factor: 2.534

7.  Induction of syncytia by the bovine C-type leukemia virus.

Authors:  C A Diglio; J F Ferrer
Journal:  Cancer Res       Date:  1976-03       Impact factor: 12.701

8.  Properties of density gradient-fractionated peripheral blood leukocytes from cattle infected with bovine leukemia virus.

Authors:  S J Kenyon; C E Piper
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

9.  Evidence of bovine C-type (leukemia) virus in dairy cattle.

Authors:  C Olson; H E Hoss; J M Miller; L E Baumgartener
Journal:  J Am Vet Med Assoc       Date:  1973-08-15       Impact factor: 1.936

10.  Studies on the relationship between infection with bovine C-type virus, leukemia, and persistent lymphocytosis in cattle.

Authors:  J F Ferrer; D A Abt; D M Bhatt; R R Marshak
Journal:  Cancer Res       Date:  1974-04       Impact factor: 12.701

View more
  19 in total

1.  Dissemination of bovine leukemia virus-infected cells from a newly infected sheep lymph node.

Authors:  B E Fulton; M Portella; K Radke
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

2.  Progression to persistent lymphocytosis and tumor development in bovine leukemia virus (BLV)-infected cattle correlates with impaired proliferation of CD4+ T cells in response to gag- and env-encoded BLV proteins.

Authors:  O Orlik; G A Splitter
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

3.  Activation of caprine arthritis-encephalitis virus expression during maturation of monocytes to macrophages.

Authors:  O Narayan; S Kennedy-Stoskopf; D Sheffer; D E Griffin; J E Clements
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

4.  Depression of B-lymphocyte levels in the peripheral blood of cows with mastitis.

Authors:  T J Yang; P A Jantzen-Abo; L F Williams
Journal:  Infect Immun       Date:  1980-01       Impact factor: 3.441

5.  Role of the proline-rich motif of bovine leukemia virus transmembrane protein gp30 in viral load and pathogenicity in sheep.

Authors:  M Reichert; A Winnicka; L Willems; R Kettmann; G H Cantor
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

6.  Enumeration of T cells, B cells and monocytes in the peripheral blood of normal and lymphocytotic cattle.

Authors:  P S Paul; D R Senogles; C C Muscoplat; D W Johnson
Journal:  Clin Exp Immunol       Date:  1979-02       Impact factor: 4.330

7.  Acid alpha-naphthyl acetate esterase: presence of activity in bovine and human T and B lymphocytes.

Authors:  T J Yang; P A Jantzen; L F Williams
Journal:  Immunology       Date:  1979-09       Impact factor: 7.397

8.  The prevalence of proviral bovine leukemia virus in peripheral blood mononuclear cells at two subclinical stages of infection.

Authors:  M L Mirsky; C A Olmstead; Y Da; H A Lewin
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

9.  Properties of density gradient-fractionated peripheral blood leukocytes from cattle infected with bovine leukemia virus.

Authors:  S J Kenyon; C E Piper
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

10.  Factors affecting the infectivity of lymphocytes from cattle with bovine leukosis virus.

Authors:  B A Buxton; R D Schultz
Journal:  Can J Comp Med       Date:  1984-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.